Informace o publikaci

Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth

Autoři

FESIUK Aleksandra POLOSKE Daniel DE ARAUJO Elvin D. FRERE Geordon A. WRIGHT Timothy B. TIN Gary RAOUF Yasir S. OLAOYE Olasunkanmi O. PARK Ji Sung BLAVET Nicolas TICHÝ Boris SCHLEDERER Michaela HOGLER Sandra WOLF Michael PHILIPPE Cecile AKSOY Osman VARADY Adam MEDAGLIA MATA Alejandro Antonio VARENICJA Maxim SZABO Boglarka WEISS Theresa WASINGER Gabriel REDMER Torben NEUBAUER Heidi A. SUSANI Martin SPIELVOGEL Clemens P. NING Jing DAHLHOFF Maik SCHEPELMANN Martin KENNEDY Richard MORIGGL Richard BROWN Geoffrey PERSSON Jenny GERNER Christopher BYSTRÝ Vojtěch HOLLOCZKI Oldamur HEERY David M. GUNNING Patrick T. MERKEL Olaf HANTUSCH Brigitte KENNER Lukas

Rok publikování 2025
Druh Článek v odborném periodiku
Časopis / Zdroj Molecular Cancer
Fakulta / Pracoviště MU

Středoevropský technologický institut

Citace
www https://link.springer.com/article/10.1186/s12943-025-02451-2?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=clarivate
Doi https://doi.org/10.1186/s12943-025-02451-2
Klíčová slova Thyroid hormone receptor beta; Prostate cancer; NH-3; Androgen receptor; Murine PCa model
Popis Thyroid hormone (TH) signaling plays a major role in the development, energy homeostasis, and metabolism of most tissues. Recent studies have identified THs as drivers of prostate cancer (PCa) development and progression. We reported that the T3-scavenger protein mu -crystallin (CRYM) regulates the development and progression of PCa and that this involved crosstalk with androgen receptor (AR) signaling. However, the mechanisms remain incompletely understood. Here, we explored the role of thyroid hormone receptor beta (TR beta), which is the main effector of TH signaling, in the context of PCa. The use of the TR beta-selective antagonist NH-3 inhibited PCa cell proliferation in vitro and reduced tumor size in PCa xenograft models in vivo. Notably, NH-3 was highly effective in the engrafted 22Rv1 cell line, a model for castration-resistant PCa (CRPC). Mechanistic studies revealed that NH-3 downregulates AR and the AR target genes Nkx3.1 and KLK3 (PSA). NH-3 was a more effective anticancer agent than enzalutamide, and their combined use was synergistic. Evidence from human datasets corroborates our findings, whereby elevated TR beta expression and mutations in the TH signaling pathway are associated with the onset of PCa. Collectively, these results establish TR beta as a mediator of tumorigenesis in PCa and identify NH-3 as a promising therapeutic agent for targeting AR signaling, particularly in CRPC.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info